ArticleInternational journal of hematology2011
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
Katsuhiro Miura et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it